Antitope to Present at the ELRIG Conference in Bournemouth, UK, 24th September 2008
Dr. Matthew Baker, CSO of Antitope, will give a presentation on ‘Overcoming Adverse Immunogenicity Against Therapeutic Antibodies' at the European Laboratory Robotics Interest Group Conference in Bournemouth UK, 24th September 2008.
Dr Baker's presentation will discuss data from clinical studies showing one of the major issues with therapeutic antibodies is the development of an anti-therapeutic antibody response within patients. The presentation will show several case studies providing evidence that the number and potency of T cell epitopes in the sequence of the therapeutic antibody is correlated to the immunogenicity observed in patients
For more information, visit the conference website at http://www.elrig.org/index.php?option=com_content&task=view&id=159&Itemid=52